Web-based nutrition management for people with cancer
Official title: Web-based Platform for Nutrition Management in Patients With Cancer: A Randomized Clinical Trial
Run by West China Hospital · NCT07307404 · Data updated 2026-11-12
This project will try a smartphone app to help adults with cancer in Chengdu spot nutrition risks, get dietary advice, and be referred to clinical dietitians.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 84 (estimated) |
| Sponsor | West China Hospital Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Status | Recruiting |
| Started | December 30, 2025 |
| Main results expected | October 30, 2026 |
| Study ends | April 30, 2027 |
| Registry record updated | December 29, 2025 |
| Trial ID | NCT07307404 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with a pathologically confirmed malignant tumor, PG-SGA score 4–9, expected survival >1 year, and sufficient cognitive and reading ability to use the app and complete questionnaires are ideal candidates.
✕Probably not a fit
Patients with severe digestive or metabolic conditions, those in cachexia or refractory cachexia stages, or those with cognitive impairment or CNS metastases (or who cannot use a smartphone) are unlikely to benefit from this app-based approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Community management teams in Chengdu will register adults with pathologically confirmed malignancies and screen them using eligibility criteria including a PG-SGA score of 4–9. Eligible patients will be offered a dedicated app for initial nutritional assessment and ongoing nutrition care, with data collected on demographics, tumor type, treatment, and smartphone use. Patients identified at nutritional risk through the app will be referred for face-to-face consultations with the research team's clinical nutritionists and may undergo additional tests such as body composition analysis. The intervention combines remote app-based monitoring and local clinical nutrition follow-up coordinated with West China Hospital.
Why it matters
Potential benefit: If successful, the app could enable earlier detection of nutritional problems and faster access to dietitian-led care, potentially improving nutritional status and tolerance of cancer treatment.
How similar studies have gone: Related digital nutrition programs and community screening efforts have shown promise in improving identification and referral for malnutrition in cancer, but results have been mixed and context-dependent.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pathologically confirmed malignant tumor; * PG-SGA score of 4-9 points; * Age: ≥18 years, with an expected survival time of more than 1 year; * Possesses adequate cognitive and reading abilities to complete questionnaires and use the APP. Exclusion Criteria: * Presence of neurological or psychiatric disorders affecting cognitive function, including central nervous system metastasis of tumors; * Suffering from conditions severely impacting digestion, metabolism, or food intake; * Patients in the cachexia stage or refractory cachexia phase.
Where it's running
-
West China hospital
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Xingchen Peng
- Email: pxx2014@163.com
- Phone: 18980606753
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neoadjuvant Cryo-Thermal Ablation with Toripalimab and Chemo for Resectable NSCLC
This study tests whether using Cryo-Thermal Ablation before chemo-immunotherapy helps people with resectable NSCLC see better outcomes.
-
Tai Chi during radiotherapy for head and neck cancer fatigue
This trial tests whether a 12-week Yang-style Tai Chi program added to usual care can reduce cancer-related fatigue in adults with head and neck cancer undergoing radiotherapy.
-
Wireless home prehabilitation for older adults with NSCLC awaiting lung surgery
This study tests whether a personalized home exercise program guided by wearable devices can improve lung function for older NSCLC patients preparing for curative lung surgery.
-
First-line combo therapy with GnP, SHR-1701, and Apatinib for metastatic pancreatic cancer
This trial tests whether adding SHR-1701 and Apatinib to standard GnP can safely and effectively treat previously untreated metastatic pancreatic cancer.
-
Early warning and stratified diagnosis of postoperative respiratory failure using ventilator waveform features
This study tests whether patterns in ventilator waveforms can predict and categorize risk of breathing failure after surgery for adults on mechanical ventilation.
-
JWK001 subretinal therapy for neovascular AMD
This study tests a single subretinal dose of JWK001 at different levels in people with wet age-related macular degeneration who have previously responded to anti-VEGF treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.